Pharmaceutical Chamber queries controversial drug imports


Colombo (Information 1st) – The Sri Lanka Chamber of the Pharmaceutical Business (SLCPI) has raised issues over media and social media stories stating that the Minister of Well being obtained cupboard approval to buy numerous pharmaceutical merchandise to be used within the well being sector from two producers in India on an pressing foundation. 

It highlighted that the stories particularly said that neither the manufacturing websites nor the merchandise to be bought are registered with the Nationwide Medicines Regulatory Authority (NMRA), which is the only real and ultimate authority that determines what prescription drugs are to be imported and used within the nation. 

In a letter addressed to the NMRA, the SLCPI quoted information stories stating that the Well being Minister had personally visited India in relation to procuring these merchandise and the settlement has been finalized.

“Such actions give rise to critical issues within the business and units a harmful precedent,” the SLCPI said.

It additionally questioned whether or not such actions have been consistent with the NMRA Act of 2015.

The Sri Lanka Chamber of the Pharmaceutical Business sought clarification relating to the media stories and raised its objections in opposition to such actions whether it is true.

See letter under:

Newest Information

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *